Ekso Bionics Holdings Inc (EKSO) — Cash Flow-to-Debt Ratio
Ekso Bionics Holdings Inc (EKSO) has a Cash Flow-to-Debt Ratio of -0.15x as of March 2026, meaning its operating cash flow of $-2.12 Million could theoretically repay 0% of its total liabilities ($13.93 Million) in one year. Check earnings quality score of Ekso Bionics Holdings Inc to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Ekso Bionics Holdings Inc Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Ekso Bionics Holdings Inc across 14 annual periods. Also explore EKSO total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Ekso Bionics Holdings Inc (2012–2025)
Year-by-year debt coverage analysis for Ekso Bionics Holdings Inc. For market capitalisation and broader financial context, see Ekso Bionics Holdings Inc market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.06x | $-11.80 Million | $11.08 Million | ▼ -50.8% |
| 2024 | -0.71x | $-9.85 Million | $13.95 Million | ▲ +4.5% |
| 2023 | -0.74x | $-12.05 Million | $16.31 Million | ▲ +22.2% |
| 2022 | -0.95x | $-14.69 Million | $15.46 Million | ▼ -1.7% |
| 2021 | -0.93x | $-11.16 Million | $11.95 Million | ▼ -72.4% |
| 2020 | -0.54x | $-8.76 Million | $16.16 Million | ▲ +48.1% |
| 2019 | -1.04x | $-15.77 Million | $15.12 Million | ▲ +29.7% |
| 2018 | -1.48x | $-22.16 Million | $14.93 Million | ▲ +21.1% |
| 2017 | -1.88x | $-31.23 Million | $16.60 Million | ▼ -34.7% |
| 2016 | -1.40x | $-25.00 Million | $17.89 Million | ▼ -78.9% |
| 2015 | -0.78x | $-18.27 Million | $23.39 Million | ▲ +44.4% |
| 2014 | -1.41x | $-15.01 Million | $10.67 Million | ▼ -65.6% |
| 2013 | -0.85x | $-11.99K | $14.12K | ▲ +0.0% |
| 2012 | -0.85x | $-11.99K | $14.12K | — |